Find uplifting stories about heroes, innovations, and solutions
10928 results for "vaccine production"
For the first time in over three years, preventive cholera vaccination campaigns are restarting worldwide as global vaccine production has doubled. Mozambique became the first country to receive doses, with 20 million vaccines now heading to three nations hit hardest by outbreaks.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
South Africa is rolling out millions of vaccines to protect livestock from foot-and-mouth disease, combining imports with renewed local production. Farmers are stepping up biosecurity as the country builds toward vaccine independence.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
African nations are building their own vaccine production systems after being left at the back of the line during global health crises. A $1.2 billion initiative and new manufacturing hubs are turning dependence into self-reliance.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
China is building its first factory for AI-powered personalized cancer vaccines that could help millions of patients each year. The technology analyzes each patient's unique tumor DNA to create custom treatments in just one day.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
For the first time in over three years, countries can now prevent cholera outbreaks before they start, thanks to doubled vaccine production. Mozambique just launched the first preventive campaign, with Bangladesh and DR Congo next in line.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
South Africa is mounting an ambitious campaign to vaccinate 80% of its 14 million cattle against foot and mouth disease by December, with international partners and revived local production coming together to protect the country's herds.
A routine vaccine millions get for shingles might be doing something remarkable: protecting hearts for years afterward. New research on 70,000 Americans reveals an unexpected health bonus that could change how we think about vaccines.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
Showing 20 of 10928